Executive Summary Parkinson’s Disorder Drugs Market: Share, Size & Strategic Insights
CAGR Value
The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period
For an excellent outcome of Parkinson’s Disorder...
Executive Summary Parkinson’s Disorder Drugs Market: Share, Size & Strategic Insights
CAGR Value
The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period
For an excellent outcome of Parkinson’s Disorder...
Personalized medicine is transforming PD care, moving beyond generic treatments to tailor therapies to genetic and symptom profiles. This shift enhances efficacy and reshapes the PD therapeutics market, as firms invest in tools to identify patient subgroups.
Genetic testing (LRRK2, GBA mutations) guides targeted therapies. Only 20% of high-income PD patients test genetically (2023 AJN study)....